Results 181 to 187 of about 12,466 (187)

Systemic Inflammation and Risk of Thromboembolism, Mortality, and Treatment Response in Patients With Cancer Receiving Immune Checkpoint Inhibitors

European Journal of Clinical Investigation, Volume 56, Issue 8, August 2026.
In patients with cancer receiving immune checkpoint inhibitors, systemic inflammatory indices measured at treatment initiation and during the first 3 months were associated with treatment response, survival, and thromboembolism, supporting their potential utility for risk stratification. ABSTRACT Background Immune checkpoint inhibitors (ICI) are widely
Leyla Ay, Ingrid Pabinger, Matthias Preusser, Anna Sophie Berghoff, Christoph Hoeller, Cihan Ay, Florian Moik   +6 more
wiley   +1 more source

Optimising hyperacute intracerebral haemorrhage management: factors influencing timely intervention

Internal Medicine Journal, Volume 56, Issue 8, Page 1394-1401, August 2026.
Abstract Background Bundled‐care protocols, which include rapid lowering of blood pressure, have improved functional outcomes in patients with intracranial haemorrhage (ICH). Specifically, the intensive blood pressure reduction in acute cerebral hemmorhage trail (INTERACT) 3 trial aimed to achieve rapid lowering of systolic blood pressure (SBP) to 140 ...
Edmund Proper, Thanh Phan, Henry Ma, Michael Valente   +3 more
wiley   +1 more source

[Intrabone meningioma: about two cases]. [PDF]

Pan Afr Med J, 2018
Nasri S, Marzouki Z, Kamaoui I, Skiker I.   +3 more
europepmc   +1 more source

Metabolic adaptation of myeloid cells in the glioblastoma microenvironment. [PDF]

Front Immunol
Essakhi N, Bertucci A, Baeza-Kallee N, Colin C, Lavignolle-Heguy R, Garcia-Gonzalez P, Argüello RJ, Tchoghandjian A, Tabouret E.   +8 more
europepmc   +1 more source